Table 2. Clinical and pathologic characteristics (N = 160).
| Characteristic | Valuea |
|---|---|
| Age at surgery, median (range), y | 52.5 (30–86) |
| Diagnosis (n = 159) | |
| Invasive ductal | 132 (83.0) |
| Invasive ductal/lobular | 9 (5.7) |
| Invasive lobular | 9 (5.7) |
| Other | 9 (5.7) |
| HER2/neu status (n = 159) | |
| 0 | 47 (29.6) |
| 1 | 34 (21.4) |
| 2 | 7 (4.4) |
| 3 | 71 (44.7) |
| Stage (n = 152) | |
| 1 | 42 (27.6) |
| 2 | 71 (46.7) |
| 3 | 39 (25.7) |
| Grade (n = 125) | |
| 1 | 4 (3.2) |
| 2 | 63 (50.4) |
| 3 | 58 (46.4) |
| Estrogen receptor status (n = 125) | |
| Negative | 33 (26.4) |
| Low | 65 (52.0) |
| High | 27 (21.6) |
| Progesterone receptor status (n = 125) | |
| Negative | 36 (28.8) |
| Low | 68 (54.4) |
| High | 21 (16.8) |
| Age | |
| ≤55 y | 88 (55.0) |
| >55 y | 72 (45.0) |
a Data are shown as No. (%) unless otherwise indicated.